National Comprehensive Cancer Network

140 articles about National Comprehensive Cancer Network

• New NCCN Guidelines Debut to Manage Complications and Improve Readiness for Stem Cell Transplant Recipients

  10/30/2019

  National Comprehensive Cancer Network expands resources to meet growing utilization of cell-based cancer treatments

• National Comprehensive Cancer Network Oncology Research Program Supports Clinical Trial for Lung Cancer

  10/28/2019

  Phase II randomized trial led by investigators at Fox Chase Cancer Center will look at chemotherapy combinations for people with stage IV non-squamous non-small cell lung cancer with EGFR mutation or who never smoked

• Flatiron Health Announces Clinical Decision Support Application Through Epic’s App Orchard

  10/16/2019

  Flatiron Assist™ to Integrate Clinical Decision Support Tools Within Oncology Workflows

• Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients, According to New Study

  10/10/2019

  Research from the O'Neal Comprehensive Cancer Center at UAB finds patients treated outside of NCCN Guidelines recommendations had significantly higher direct costs

• International Collaboration to Improve Cancer Care in Sub-Saharan Africa Announces Management of Most Adult Cancers Covered by NCCN Harmonized Guidelines

  8/28/2019

  A collaborative project from the National Comprehensive Cancer Network®, the African Cancer Coalition, the American Cancer Society, and others to improve cancer outcomes in Sub-Saharan Africa enters a new phase in Addis Ababa, Ethiopia.

• NCCN Updates Spanish Adaptations of NCCN Guidelines to Enable Better Cancer Prevention, Diagnosis, and Treatment in Spain

  8/20/2019

  New and improved mobile app and upcoming NCCN Global Academy event reflect the organization's efforts to increase worldwide access to NCCN resources. #NCCNGlobal

• New NCCN Guidelines Are First to Address Small Intestine Cancers; Updates Highlight Developments in Genetic Testing and Hereditary Risk for Colon and Other Intestinal Cancers

  8/1/2019

  New NCCN Guidelines for Small Bowel Adenocarcinoma are first clinical guidelines in the United States to address this rare but growing cancer type, which is sometimes associated with hereditary causes like Lynch syndrome

• NCCN issues first pediatric acute lymphoblastic leukemia guidelines, including use of Voraxaze®

  7/11/2019

  BTG plc, the global healthcare company, highlighted the first publication of National Comprehensive Cancer Network pediatric acute lymphoblastic leukemia guidelines including consideration of Voraxaze®.

• New Patient Resource from NCCN Helps People with Bladder Cancer Make Informed Treatment Decisions

  6/26/2019

  New NCCN Guidelines for Patients: Bladder Cancer explains the lengthy surveillance process that follows active treatment for the sixth most-common cancer in the United States.

• NCCN Advances Cancer Research and Oncology Career Development with Young Investigator Awards, Poster Presentations, and Fellows Program

  5/8/2019

  The National Comprehensive Cancer Network supports cancer research and treatment through various programs during and after the NCCN 2019 Annual Conference.

• CDC Issues Key Clarification on Guideline for Prescribing Opioids for Chronic Pain

  4/9/2019

  Agency Clarifies CDC Guideline Not Meant to Limit Access to Appropriate Pain Management for Individuals with Cancer, Sickle Cell Disease

• NCCN 2019 Annual Conference Addresses How to Improve Cancer Care Worldwide Amid Intersecting Public Health Crises

  4/3/2019

  Oncology professionals from all over the world met in Orlando to discuss how to better address the needs of people with cancer. Join the conversation online with the hashtag #NCCNac19

• National Comprehensive Cancer Network Recognizes Five Individuals for Outstanding Achievements in Improving Cancer Care

  4/2/2019

  National Comprehensive Cancer Network® (NCCN®) today announced the recipients of a series of awards honoring individuals whose significant contributions fueled progress in improving and facilitating quality, effective, efficient, and accessible cancer care over the past year.

• MD Anderson's Dr. Ronald Walters Named New Board Chair for National Comprehensive Cancer Network

  3/28/2019

  Dr. Walters elected chair of the Board of the alliance of leading cancer centers; UW Carbone's Ruth O'Regan elected Vice-Chair

• NCCN Announces Six Quality Improvement Projects in Gastric Cancer Care Approved for Collaboration with Lilly Oncology

  3/20/2019

  The quality improvement studies will focus on methods of intervention that can be implemented across a variety of different oncology practice settings.

• BRAFTOVI® (encorafenib) in Combination with MEKTOVI® (binimetinib) and ERBITUX® (cetuximab) or panitumumab Recommended by the NCCN Guidelines as a Treatment Option for Patients with Advanced BRAF-mutant Colorectal

  3/18/2019

  Array BioPharma Inc. announced that the National Comprehensive Cancer Network® has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to include BRAFTOVI® in combination with MEKTOVI® and an anti-EGFR antibody as a Category 2a treatment for patients with BRAFV600E-mutant metastatic colorectal cancer, after failure of one or two prior lines of therapy for metastatic disease.

• NCCN Awards Grants to Investigators to Study Trifluridine and Tipiracil in Various Cancers

  3/14/2019

  The studies will be funded through a collaboration between the NCCN Oncology Research Program and Taiho Oncology, Inc. to investigate the effectiveness of trifluridine and tipiracil

• New Patient Resource from NCCN Clears up Confusion around Highly Common Type of Skin Cancer

  2/28/2019

  New NCCN Guidelines for Patients: Squamous Cell Skin Cancer explains risk factors and treatment options for cancer type that impacts millions every year.

• Integrating Heart Disease and Cancer Care Could Reduce Overall Health Care Costs, According to Researchers

  2/20/2019

  Study in JNCCN finds coronary artery disease costs increase dramatically in patients who are diagnosed with cancer

• National Comprehensive Cancer Network Updates Resources for Improving Cancer Care in the Middle East & North Africa

  1/29/2019

  NCCN Adaptations updated to streamline care and encourage best practices for cancer treatment in the MENA region